Canbridge Pharmaceuticals (1228.HK)

Canbridge Pharmaceuticals share price today, ATLAS forecast and fair value

Healthcare · Biotechnology · Hong Kong Exchanges (HKEX) · Hong Kong SAR China

HK$1.82▼ -1.09%

Prices as of Oct 27, 2026 · HKD

ATLAS fair value

HK$1.04

Above fair value · 75% premium

Range: HK$0.936–HK$1.14Fair valuePrice

Chance of rising in 1 month

46%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Canbridge Pharmaceuticals in ATLAS

ATLAS's own quantitative analysis, all in one place.

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.

See everything included

Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

On Canbridge Pharmaceuticals

Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
Officers and shareholdersWho runs the company and which funds hold its shares.
Customer and supplier mapWho it does business with, from its own filings.
Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
NewsThe latest on the company, in one place.

And for you

ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
AlertsWe let you know when something changes in your stocks.
Crisis simulatorHow your portfolio would do in a crash like 2008.
Practice risk-free$10,000 in virtual money to invest at real prices.
Global screenerSearch US stocks and stocks from 47 countries with filters.

Get started →

Plans from €3.99 a month.

ATLAS estimates Canbridge Pharmaceuticals's fair value at about HK$1.04 per share (reasonable range: HK$0.936 to HK$1.14). At HK$1.82, the stock trades 75% above it.

It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Canbridge Pharmaceuticals a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between HK$1.55 and HK$2.05; in 9 out of 10, between HK$1.22 and HK$2.61. Estimated annual volatility is 60%.

Price, last 12 months (weekly close)

Key numbers

Market cap: HK$1.1B
Market cap (USD): $138M
52-week high: HK$3.50
52-week low: HK$1.61
Revenue (12 months): CN¥55.7M
Gross margin: 72.9%
Operating margin: -172.1%
Net margin: -146.4%
Beta: -0.16

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Canbridge Pharmaceuticals sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks 1228.HK has traded between HK$1.61 and HK$3.50. Today it is 48.0% below that high and 13% above its low.

Its beta is -0.16: it tends to move less than the market.

About the company

CANbridge Pharmaceuticals Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.

Want to see everything about Canbridge Pharmaceuticals?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Canbridge Pharmaceuticals (1228.HK) fair value?

About HK$1.04 per share according to ATLAS (reasonable range: HK$0.936 to HK$1.14). With the stock at HK$1.82, it is 75% above it.

What is the chance 1228.HK goes up next month?

46%: close to a coin flip. In half of the simulated outcomes, 1228.HK ends the month between HK$1.55 and HK$2.05.

How big is Canbridge Pharmaceuticals and what is its P/E ratio?

Canbridge Pharmaceuticals's market capitalization is HK$1.1B. We do not show a P/E because it has no positive earnings to base one on.

How volatile is 1228.HK?

ATLAS estimates annual volatility at 60%. In a typical month, half of the outcomes end between HK$1.55 and HK$2.05.

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer